{"id":16056,"name":"OCCIDENT","slug":"occident","website":"https://www.occident.group","hqGeo":"Germany","stageFocus":["Seed"],"sectorTags":["Healthcare","Security"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"OCCIDENT invests in industrial biotech and has explicitly backed a peptide-production company at seed stage. The peptide and biotech orientation is highly relevant for a bioactive peptide startup, even though the use case is adjacent to beauty rather than therapeutics.","thesisNarrative":null,"logoUrl":null,"aumUsd":500000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Immitra Bio","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Neue Plattform für die In-vivo-Gentherapie bei seltenen genetischen Erkrankungen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lymphatica","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Medizin­technik­unternehmen zur Behandlung von Lymph­ödemen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Altavo","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"MedTech-Startup zur Verbesserung der Rehabilitation von stimm­losen Menschen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Chipmetrics","companyUrl":null,"stage":null,"sector":"Industrial Tech","investmentYear":null,"description":"Entwicklung und Produktion innovativer Messchips und Wafer für die Halb­leiter­industrie.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ReCatalyst","companyUrl":null,"stage":null,"sector":"Industrial Tech","investmentYear":null,"description":"Entwicklung innovativer Katalysatoren für Brennstoffzellen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"EBAMed","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Medizin­technik­unternehmen im Bereich der Protonen­therapie.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"core sensing","companyUrl":null,"stage":null,"sector":"Industrial Tech","investmentYear":null,"description":"Entwicklung innovativer Sensor­technologie für Maschinenbau.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Avelo","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Diagnostik-Startup zur Verbesserung der Diagnose von Atemwegsinfektionen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"hemotune","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung einer Plattformtechnologie zur extrakorporalen Blutreinigung.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Algiax Pharmaceuticals","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung innovativer Produkte zur Behandlung von Krankheiten mit hohem medizinischen Bedarf.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Thermosome","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Gezielte Tumortherapie zur Verbesserung der Krebsbehandlung.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Resistell","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Technologie zur präziseren Identifikation von Antibiotikaresistenzen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"G-Metrics","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung disruptiver Lösungen für die Augenheilkunde.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"InSphero","companyUrl":null,"stage":null,"sector":"Digital","investmentYear":null,"description":"Anbieter von 3D-Assay-Lösungen zur prädiktiven Klassifizierung von Wirkstoffen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"iMusician","companyUrl":null,"stage":null,"sector":"Digital","investmentYear":null,"description":"Urheberrechtliche Dienstleistungen für Musiker weltweit.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tubulis","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung neuartiger Antikörper-Wirkstoff-Konjugate.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"adivo","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Technologieplattform für therapeutische Antikörper in der Veterinärmedizin.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lunaphore","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung eines Testverfahrens zur Analyse von Tumorgewebe.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versantis","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung von Medikamenten für die Behandlung von Lebererkrankungen.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"GNA Biosolutions","companyUrl":null,"stage":null,"sector":"Lifesciences","investmentYear":null,"description":"Entwicklung einer disruptiven PCA-Technologie zur DNA-Analyse.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"cunesoft","companyUrl":null,"stage":null,"sector":"Digital","investmentYear":null,"description":"Entwicklung einer Softwareplattform für die pharmazeutische Industrie.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"kooaba","companyUrl":null,"stage":null,"sector":"Digital","investmentYear":null,"description":"Entwicklung einer Augmented-Reality-Technologieplattform zur Bilderkennung.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"mk2 Biotechnologies","companyUrl":null,"stage":"seed","sector":"industrial biotech","investmentYear":null,"description":"Munich-based industrial biotech startup developing and producing peptides","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Code Intelligence","companyUrl":null,"stage":"follow-on investment","sector":"digital / cybersecurity","investmentYear":null,"description":"Bonn-based startup focused on software security / security testing automation","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":2,"partners":[{"id":52401,"name":"Michael Pauer","title":"Chief Investment Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/michael-pauer","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":52402,"name":"Paul Sunzenauer","title":"Investment Manager","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/paul-stephan-sunzenauer","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":964,"name":"Fund III","vintageYear":2023,"sizeUsd":250000000,"status":"actively investing","focusAreas":[]},{"id":963,"name":"Fund II","vintageYear":2021,"sizeUsd":150000000,"status":"actively investing","focusAreas":[]},{"id":962,"name":"Fund I","vintageYear":2019,"sizeUsd":100000000,"status":"fully deployed","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"fund","title":"Raised Fund III ($250M)","url":null,"source":"fund records","occurredAt":"2023-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Fund II ($150M)","url":null,"source":"fund records","occurredAt":"2021-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Fund I ($100M)","url":null,"source":"fund records","occurredAt":"2019-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-10-26T02:26:47.934Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":3892,"name":"Madrona Pioneer Fund","slug":"madrona-pioneer-fund","logoUrl":null,"website":"https://www.madrona.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Real Estate","SaaS","Enterprise","Security","Developer Tools"],"hqGeo":"Seattle, WA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"investormatch-mcp-server-claude-chatgpt","title":"Your Investor List Now Lives Inside Claude and ChatGPT"},{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-30T20:18:21.940Z"}